| P50 | author | Florian Sennlaub | Q37836639 |
| | Sylvain Chemtob | Q87709523 |
| P2093 | author name string | F Behar-Cohen | |
| | E Kermorvant-Duchemin | |
| P2860 | cites work | Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity | Q24609568 |
| | Cellular actions of the insulin-like growth factor binding proteins | Q28216659 |
| | Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 |
| | Target ranges of oxygen saturation in extremely preterm infants | Q30434084 |
| | Retinopathy of prematurity. Results of fundus examination performed in 94 preterm infants | Q33203355 |
| | Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy | Q33379554 |
| | Incidence of retinopathy of prematurity in the United States: 1997 through 2005. | Q33471037 |
| | Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins | Q33775844 |
| | Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy | Q34017503 |
| | Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs | Q34408269 |
| | Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization | Q34749337 |
| | Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity | Q35108428 |
| | Threshold retinopathy at threshold of viability: the EpiBel study | Q35591750 |
| | Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis | Q35817458 |
| | Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. | Q35897076 |
| | The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina | Q35957608 |
| | IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. | Q35973404 |
| | Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors | Q36496079 |
| | Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration | Q36849847 |
| | Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy | Q37018797 |
| | Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity | Q41292409 |
| | Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia | Q41677354 |
| | Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy | Q43610753 |
| | Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy | Q44488004 |
| | Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth | Q44640538 |
| | Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration | Q44675917 |
| | Retinopathy of prematurity: 10-year retrospective study at the University Hospital of Strasbourg | Q45131328 |
| | Redox-dependent effects of nitric oxide on microvascular integrity in oxygen-induced retinopathy. | Q45140399 |
| | The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis | Q46330877 |
| | Hypercapnia prevents neovascularization via nitrative stress | Q46916507 |
| | Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening | Q47191959 |
| | Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity | Q47310528 |
| | One-year survival of extremely preterm infants after active perinatal care in Sweden | Q47567066 |
| | The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability | Q47623281 |
| | Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity | Q47629197 |
| | Peroxide-cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics | Q64883072 |
| | Circulating insulin-like growth factor I levels in newborn premature and full-term infants followed longitudinally | Q70028858 |
| | Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements | Q71296905 |
| | Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor | Q73226153 |
| | Essential role of growth hormone in ischemia-induced retinal neovascularization | Q73407423 |
| | The effect of carbon dioxide on oxygen-induced retinopathy in the neonatal rat | Q73508389 |
| | The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study | Q81920787 |
| P407 | language of work or name | French | Q150 |
| P921 | main subject | pathophysiology | Q1135939 |
| P304 | page(s) | S79-85 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | Archives de Pediatrie | Q15757206 |
| P1476 | title | Epidemiology and pathophysiology of retinopathy of prematurity | |
| P478 | volume | 18 Suppl 2 | |